Skip to main content
. Author manuscript; available in PMC: 2018 Jun 1.
Published in final edited form as: Brain Imaging Behav. 2017 Jun;11(3):640–648. doi: 10.1007/s11682-016-9541-6

Table 4.

Brain regions with significant increases in FC relative to baseline and change in placebo (Methylene Blue > Placebo and Post Intervention > Pre Intervention)

Source Seed (location) Target pFDR k z’ t
Left ventral intraparietal sulcus Right intracalcarine cortex, right lingual gyrus 0.0003 388 0.26 5.11
Posterior cingulate, precuneus Right insular cortex 0.003 265 0.22 7.72
Left frontal eyefield Left precentral gyrus, left middle frontal gyrus 0.006 254 0.25 4.92
Left temporal pole Left superior frontal gyrus, left paracingulate gyrus 0.008 258 0.25 5.7
Left intracalcarine cortex Lateral occipital cortex superior division 0.022 189 0.29 4.85
Left hippocampus Cerebellum 9 right 0.025 187 0.2 7.04
Right middle frontal gyrus Right inferior temporal gyrus (temporooccipital), temporal occipital fusiform cortex, right middle temporal gyrus (temporooccipital part), cerebellum crus1 0.031 209 0.24 5.47
Right temporal pole Left superior frontal gyrus, left paracingulate gyrus 0.037 187 0.26 4.72

Cluster corrected pFDR <0.05, k = no. of voxels (1.719 × 1.719 × 4 mm3 per voxel), z’ = Fisher corrected correlation, 26 degrees of freedom, N = 15 MB and N = 13 Placebo, detailed results in Table S1